Italian risk-sharing agreements on drugs: are they worthwhile?
Eur J Health Econ
.
2015 Jan;16(1):1-3.
doi: 10.1007/s10198-014-0585-5.
Authors
Livio Garattini
1
,
Alessandro Curto
,
Katelijne van de Vooren
Affiliation
1
CESAV, Centre for Health Economics, IRCCS Institute for Pharmacological Research 'Mario Negri', Via Camozzi, 3 c/o Villa Camozzi, Ranica, 24020, Bergamo, Italy, livio.garattini@marionegri.it.
PMID:
24728513
DOI:
10.1007/s10198-014-0585-5
No abstract available
Publication types
Editorial
MeSH terms
Cost Control
Drug Costs
Drug Industry / economics
Drug Industry / organization & administration*
Humans
Italy
Risk Sharing, Financial / economics
Risk Sharing, Financial / organization & administration*